| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | Director | Stock Option (Right to Purchase) | 42,000 | $143,220 | $3.41 | 11 Jun 2025 | Direct |
| DiaMedica Therapeutics Inc. | Chief Marketing Officer | Stock Option (right to buy) | 450,000 | 11 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | 11 Aug 2025 | 1 | $0 | 4 | Chief Marketing Officer | 03 Nov 2025, 16:32 |
| DMAC | DiaMedica Therapeutics Inc. | 11 Aug 2025 | 0 | $0 | 3 | Chief Marketing Officer | 03 Nov 2025, 16:31 |
| AQST | Aquestive Therapeutics, Inc. | 11 Jun 2025 | 1 | +$143,220 | 4 | Director | 12 Jun 2025, 13:59 |
| AQST | Aquestive Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 13:50 |
| AQST | Aquestive Therapeutics, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 12:28 |
| AQST | Aquestive Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:22 |
| AQST | Aquestive Therapeutics, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 18:50 |